ZYTO OFFICERS AND DIRECTORS
Vaughn R Cook, OMD
CEO, ZYTO Corp
Vaughn R Cook founded ZYTO and has served as Chairman of the Board and Chief Executive Officer since its incorporation in December of 2004. He has been employed full time by ZYTO since its inception. Dr. Cook is an honors graduate of Utah State University, has an acupuncture degree from the Oriental Medical Institute of Hawaii, and an OMD (Oriental Medical Doctor) degree from the North American Academy of Advanced Asian Medicine. He is board certified and licensed as an acupuncturist in Utah. For nearly thirty years Dr. Cook has worked in the Complementary and Alternative Medical field. He has specialized in technology applications that integrate western and eastern medicine. He has worked for Esion Corp, the company that developed the Interro; has been the President and owner of Digital Health Corp, the company that developed the Omega Acubase System; and President of BioMeridian International, Inc., the company that developed the MSA Pro and other related technology. He has developed multiple computer-based systems used by healthcare professionals around the world. The first was the Omega AcuBase System, and the most recent is ZYTO technology. Concurrent with his work with technology, Dr. Cook owned and operated the Utah Acupuncture Clinic and the Meridian Health Center in Salt Lake City, Utah. This clinical background has allowed him to develop equipment from the perspective of a practicing healthcare professional, which combined with an extensive background in business, has resulted in technology that is clinically effective and financially practical. He has traveled extensively and taught principles of alternative medicine throughout the United States and in many countries.
Kami J. Howard, MBA
President & COO, ZYTO Corp
Kami J. Howard joined ZYTO in April 2007 as the Chief Financial Officer and was first elected to serve as a director of the Company in October 2008. Ms. Howard was elected by our Board of Directors to serve as our Secretary on June 27, 2010 and in March 2011 was appointed by the Board of Directors to serve as the Company's President and Chief Operating Officer. As a member of our senior management team she is involved in strategic planning and is responsible for all financial, regulatory, and investor relation aspects of the business.
Prior to joining ZYTO, Ms. Howard spent five years at Browz, LLC, a technology company specializing in supply chain verification, where she served as Vice President and Company Controller for the entire length of her employment. Her responsibilities included accounting, business and tax planning on behalf of the LLC and its members. From 2000 to 2003, Ms. Howard served as Vice President and Corporate Controller for BioMeridian Corporation and its subsidiaries. Prior to her appointment at BioMeridian, Ms. Howard served in various senior financial positions. She holds a B.S. in accounting and a Master's Degree in Business Administration. Recently she recieved the Stevie Award for her accomplishments.
Hammad M. Shah, RPH, MBA
Director, ZYTO Corp
Hammad M. Shah was first elected to serve as a director of ZYTO in October 2008 and currently serves as the president of FreseniusRx. Mr. Shah champions the company’s vision to change the practice of pharmacy from simply dispensing medications to playing an integral role in patient care. His direction positions FreseniusRx to drive improved patient outcomes by connecting clinical, pharmacy and lab data to provide physicians with a complete view of each patient’s overall health.
Since joining FreseniusRx in 2012, Mr. Shah has created a growth strategy that transformed the previously full-service pharmacy into a renal specialty pharmacy, providing health care expertise to patients living with kidney disease. FreseniusRx encourages increased medication adherence, striving to decrease patient hospitalization, reduce health care costs and achieve quality patient care. Under his leadership, FreseniusRx grew from double-digit revenue to tripledigit revenue in just two and a half years. In his role, Mr. Shah also serves as a senior vice president for Fresenius Medical Care North America, parent company of FreseniusRx, to bridge the company’s pharmacy services with the larger renal division.
Mr. Shah, a registered pharmacist, has more than 20 years of experience in health care leadership, serving in senior administrative, strategic and operational roles. His business experience crosses many disciplines including product development, Medicaid, start-ups, sales, process improvement, and mergers and acquisitions.
Prior to joining FreseniusRx, he served as vice president and general manager for emerging markets at Express Scripts. He was responsible for managing a portfolio of companies, as well as supporting an acquisition strategy designed to meet inorganic, domestic health care growth goals.
Mr. Shah’s experience in health care leadership spans the globe including work in Asia and Europe during a time where specific countries in those regions, such as China, Singapore, Germany and the United Kingdom, were undergoing significant efforts to reform their health care systems. This has given him the deep expertise required to aid organizations in understanding how to operate in a rapidly changing health care market.
He carries his passion for delivering data-driven solutions beyond FreseniusRx. Mr. Shah also sits on the board of directors for Remedi Senior Care, which provides pharmacy solutions that enable long-term care facilities to reduce medication costs, improve efficiency and increase medication administration safety and accuracy.
Mr. Shah attended Arizona State University, where he earned a master’s degree in business administration and completed coursework toward a master’s degree in health sector management. He holds a bachelor’s degree in pharmacy from Temple University.